| abstract |
USES OF LABELED HSP90 INIHIBITORS Abstract of the Disclosure This invention concerns various methods of using labeled HSP90 inhibitors to improve treatment of cancer patients with HSP90 inhibitors, including ex vivo and in vivo methods for determining whether a tumor will likely respond to therapy with an HSP90 inhibitor. |